Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Sleep Cycle AB ( (SE:SLEEP) ) just unveiled an announcement.
Sleep Cycle’s 2025 year-end report shows a tightened focus on SDK licensing and health-tech partnerships—highlighted by collaborations with Ultrahuman, a global IoT player, and a CRO-backed AI sleep apnea validation study—even as subscriber attrition pulled net sales down 5.2% and trimmed operating margin to 26.6%, prompting a proposed dividend of SEK 0.53 per share to reassure investors.
The most recent analyst rating on (SE:SLEEP) stock is a Buy with a SEK28.00 price target. To see the full list of analyst forecasts on Sleep Cycle AB stock, see the SE:SLEEP Stock Forecast page.
More about Sleep Cycle AB
Sleep Cycle AB operates a consumer sleep-tracking and coaching platform centered on its mobile app, AI-driven tools like the Luma sleep coach, and software development kits that extend its technology into wearables and IoT ecosystems.
Average Trading Volume: 33,456
Technical Sentiment Signal: Sell
Current Market Cap: SEK484.6M
Learn more about SLEEP stock on TipRanks’ Stock Analysis page.